MedicSpot provides clinically-proven weight loss treatments, including GLP-1 medications, that enable patients to lose up to 26% of their body weight within 84 weeks. The service includes ongoing clinical support, behavior change courses, and a money-back guarantee for achieving at least a 5% reduction in body weight in the first year.
Funding
$3.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many individuals struggle with weight loss despite dieting, often due to underlying physiological factors like hormonal imbalances and metabolic dysregulation. Traditional weight loss methods may not address these root causes, leading to yo-yo dieting and frustration.
Solution
MedicSpot provides clinically-proven weight loss treatments, including GLP-1 receptor agonists like Mounjaro and Wegovy, that address the physiological factors affecting weight. The program includes ongoing clinical support to minimize symptoms, a behavior change course, and a free dietician consultation to help patients transition off medication. Patients receive anti-sickness tablets if clinically appropriate. MedicSpot offers a money-back guarantee if patients do not achieve at least a 5% reduction in body weight within the first year.
Target Audience
MedicSpot targets individuals who have struggled with traditional weight loss methods and are seeking clinically-proven treatments and ongoing support to achieve sustainable weight management.
Features
- Access to GLP-1 receptor agonists (e.g., Mounjaro, Wegovy) prescribed by clinicians
- Free online behavior change course with proven techniques for healthier living
- Free dietician consultation to support transition off GLP-1 medication
- Free anti-sickness tablets provided, if clinically appropriate, to minimize side effects
- Medication guarantee ensuring consistent monthly supply
- Money-back guarantee if a 5% body weight reduction is not achieved in the first year